Azurion systems with software release R2.0.x

FDA Device Recall #Z-0734-2022 — Class II — May 26, 2021

Recall Summary

Recall Number Z-0734-2022
Classification Class II — Moderate risk
Date Initiated May 26, 2021
Status Completed
Voluntary FDA Mandated

Recalling Firm

Firm Philips Healthcare
Location Andover, MA
Product Type Devices
Quantity 69 systems

Product Description

Azurion systems with software release R2.0.x

Reason for Recall

In the Azurion system, the user can add a new study to a patient by selecting the option "Add Study". The Add Study dialogue box is then displayed where the Patient Type is selected to perform the study. Due to a software defect, when the study is initiated by pressing Start Procedure , the Patient Type changes inadvertently to a Patient Type different than the one selected as shown in the Table below. Patient type is one of the factors involved in the dose control process. The incorrect patient type changes the technique factors to be used by the system without notification to the user.

Distribution Pattern

US Nationwide Distribution

Lot / Code Information

Model(s) Azurion R2.1

Other Recalls from Philips Healthcare

Recall # Classification Product Date
Z-2520-2023 Class II Incisive CT, software version 5.0 Aug 2, 2023
Z-0737-2022 Class II Philips StentBoost Live R2.0 application, when ... Feb 2, 2022
Z-0238-2022 Class II Philips Azurion systems with software releases ... Sep 24, 2021
Z-0241-2022 Class II CombiDiagnost R90 is multi-functional general R... Sep 22, 2021
Z-0240-2022 Class II ProxiDiagnost N90 is multi-functional general R... Sep 22, 2021

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.